fda warning letters glp-1 compounding september 26 2025 WRTV Investigates has learned the sent 30 to telehealth companies for illegally marketing compounded GLP-1s. MORE FDA Sends Warning Letters to

The company also operates a manufacturing plant in West Chester, which is nearly 600,000 square feet and equipped with end-to-end drug product manufacturing capabilities, including aseptic filling, inspection, packaging, labeling, and cold-chain operations for vials, cartridges, pre-filled syringes, and autoinjectors, as well as a virtual reality training center

Thats why they are the only peptide company with the distinction of being Better Business Bureau-accredited

The artificial active ingredients semaglutide, liraglutide, and tirzepatide bind to the same receptors

As we age, NAD+ levels naturally decline, which can impact energy, mental clarity, and cellular health

A., Anker, S